Literature DB >> 9297720

Factors predicting pituitary adenoma invasiveness in acromegalic patients.

A Rieger1, N G Rainov, H Ebel, L Sanchin, K Shibib, C Helfrich, O Hoffmann, W Burkert.   

Abstract

Forty-four adult acromegalic patients carrying growth hormone-producing pituitary macroadenomas were investigated with neuroradiological and endocrinological techniques. Plasma growth hormone and somatomedin-C levels were repeatedly measured before surgical removal of tumors and during the follow-up period. Twenty-five patients presented preoperatively with an invasive adenoma that involved the cavernous sinus (CS). Diagnosis of tumor invasivity was made according to distinct neuroradiological criteria and was confirmed or rejected during surgery Significantly higher basal growth hormone levels were found in patients with CS invasion than in cases without tumor growth in the CS. Evidence is presented that plasma growth hormone level in acromegalics is a more sensitive indicator for predicting tumor invasiveness than somatomedin-C. Growth hormone basal values before surgery and the extent of their decrease after removal of tumor correlate with adenoma growth in the parasellar compartments and should be used as a prognostic factor to aid in planing adjuvant tumor treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9297720     DOI: 10.1007/BF01105562

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  28 in total

Review 1.  Acromegaly.

Authors:  S Melmed
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245

2.  Transsphenoidal surgery for acromegaly--long-term results in 100 patients.

Authors:  F Grisoli; T Leclercq; P Jaquet; M Guibout; J P Winteler; J Hassoun; F Vincentelli
Journal:  Surg Neurol       Date:  1985-05

3.  Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.

Authors:  G T Tindall; N M Oyesiku; N B Watts; R V Clark; J H Christy; D A Adams
Journal:  J Neurosurg       Date:  1993-02       Impact factor: 5.115

4.  Invasiveness of pituitary adenomas.

Authors:  D Sautner; W Saeger
Journal:  Pathol Res Pract       Date:  1991-06       Impact factor: 3.250

5.  Pathology of growth hormone-producing tumors of the human pituitary.

Authors:  K Kovacs; E Horvath
Journal:  Semin Diagn Pathol       Date:  1986-02       Impact factor: 3.464

6.  Results of surgical treatment for growth hormone-secreting pituitary adenomas.

Authors:  D H Davis; E R Laws; D M Ilstrup; J K Speed; M Caruso; E G Shaw; C F Abboud; B W Scheithauer; L M Root; C Schleck
Journal:  J Neurosurg       Date:  1993-07       Impact factor: 5.115

Review 7.  Pituitary gland.

Authors:  E Horvath; K Kovacs
Journal:  Pathol Res Pract       Date:  1988-04       Impact factor: 3.250

8.  Transmaxillosphenoidal approach to tumors invading the medial compartment of the cavernous sinus.

Authors:  B Fraioli; V Esposito; A Santoro; G Iannetti; R Giuffrè; G Cantore
Journal:  J Neurosurg       Date:  1995-01       Impact factor: 5.115

9.  Transsphenoidal surgery of parasellar pituitary adenomas.

Authors:  R Fahlbusch; M Buchfelder
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

10.  Investigation of the criteria for assessing the outcome of treatment in acromegaly.

Authors:  J Lindholm; B Giwercman; A Giwercman; J Astrup; P Bjerre; N E Skakkebaek
Journal:  Clin Endocrinol (Oxf)       Date:  1987-11       Impact factor: 3.478

View more
  9 in total

1.  Gamma knife radiosurgery for clinically persistent acromegaly.

Authors:  Xiaomin Liu; Hideyuki Kano; Douglas Kondziolka; Kyung-Jae Park; Aditya Iyer; Ajay Niranjan; John C Flickinger; L Dade Lunsford
Journal:  J Neurooncol       Date:  2012-04-26       Impact factor: 4.130

2.  CyberKnife robotic radiosurgery in the multimodal management of acromegaly patients with invasive macroadenoma: a single center's experience.

Authors:  Elisa Sala; Justin M Moore; Alvaro Amorin; Hector Martinez; Aprotim C Bhowmik; Layton Lamsam; Steven Chang; Scott G Soltys; Laurence Katznelson; Griffith R Harsh
Journal:  J Neurooncol       Date:  2018-02-10       Impact factor: 4.130

3.  Aggressive somatotrophinomas lacking clinical symptoms: neurosurgical management.

Authors:  Mario Giordano; Amir Samii; Rudolf Fahlbusch
Journal:  Neurosurg Rev       Date:  2017-12-30       Impact factor: 3.042

4.  Invasive pituitary adenomas: significance of proliferation parameters.

Authors:  A P Amar; D R Hinton; M D Krieger; M H Weiss
Journal:  Pituitary       Date:  1999-08       Impact factor: 4.107

5.  The therapeutic response of somatotropinomas according to the T2-weighted signal intensity on the MRI.

Authors:  Carla-Liana Scânteie; Daniel-Corneliu Leucuţa; Cristina Ghervan
Journal:  Med Pharm Rep       Date:  2021-10-30

6.  Pretreatment serum GH levels and cardio-metabolic comorbidities in acromegaly; analysis of data from Iran Pituitary Tumor Registry.

Authors:  Leila Hedayati Zafarghandi; Mohammad Ebrahim Khamseh; Milad Fooladgar; Shahrzad Mohseni; Mostafa Qorbani; Nahid Hashemi Madani; Mahboobeh Hemmatabadi; MohammadReza Mohajeri-Tehrani; Nooshin Shirzad
Journal:  J Diabetes Metab Disord       Date:  2020-04-05

7.  Efficacy and complications of neurosurgical treatment of acromegaly.

Authors:  Anna Krzentowska-Korek; Filip Gołkowski; Agata Bałdys-Waligórska; Alicja Hubalewska-Dydejczyk
Journal:  Pituitary       Date:  2011-06       Impact factor: 4.107

8.  Using growth hormone levels to detect macroadenoma in patients with acromegaly.

Authors:  Ji Young Park; Jae Hyeon Kim; Sun Wook Kim; Jae Hoon Chung; Yong Ki Min; Myung Shik Lee; Moon Kyu Lee; Kwang Won Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2014-05-27

9.  Robotic Radiosurgery for Persistent Postoperative Acromegaly in Patients with Cavernous Sinus-Invading Pituitary Adenomas-A Multicenter Experience.

Authors:  Felix Ehret; Markus Kufeld; Christoph Fürweger; Alfred Haidenberger; Paul Windisch; Susanne Fichte; Ralph Lehrke; Carolin Senger; David Kaul; Daniel Rueß; Maximilian Ruge; Christian Schichor; Jörg-Christian Tonn; Günter Stalla; Alexander Muacevic
Journal:  Cancers (Basel)       Date:  2021-01-31       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.